
Walgreens Boots Alliance (WBA) surpassed third-quarter profit estimates, reporting adjusted EPS of $0.38 against expectations of $0.34, with U.S. retail pharmacy sales reaching $30.71 billion and same-store sales up 10.3%. This performance, driven by ongoing store closures and cost-cutting, provides a positive note as the company proceeds with its $10 billion privatization by Sycamore Partners, a deal expected to close by year-end and reflecting a substantial decline from its $100 billion valuation a decade prior.
Walgreens Boots Alliance (WBA) reported third-quarter results that surpassed analyst expectations, driven by its ongoing turnaround initiatives. The company posted an adjusted earnings per share of $0.38, beating the LSEG average estimate of $0.34, while its U.S. retail pharmacy unit generated sales of $30.71 billion against a forecast of $29.01 billion. This outperformance was supported by a robust 10.3% increase in same-store sales and attributed to the execution of cost-cutting measures and store closures. This operational progress is occurring within the critical context of WBA's pending privatization by Sycamore Partners for $10 billion, a transaction expected to close by the end of the year. The deal value starkly contrasts with the company's $100 billion valuation a decade prior, underscoring the significant long-term challenges it has faced from strategic missteps and adverse industry dynamics like low drug reimbursement rates.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment